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Abstract
Previous studies have suggested that naturally occurring genetic variation contributes to the risk of astigmatism. The purpose 
of this investigation was to identify genetic markers associated with corneal and refractive astigmatism in a large-scale Euro-
pean ancestry cohort (UK Biobank) who underwent keratometry and autorefraction at an assessment centre. Genome-wide 
association studies for corneal and refractive astigmatism were performed in individuals of European ancestry (N = 86,335 
and 88,005 respectively), with the mean corneal astigmatism or refractive astigmatism in fellow eyes analysed as a quan-
titative trait (dependent variable). Genetic correlation between the two traits was calculated using LD Score regression. 
Gene-based and gene-set tests were carried out using MAGMA. Single marker-based association tests for corneal astig-
matism identified four genome-wide significant loci (P < 5 × 10−8) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), 
HERC2/OCA2 (15q13.1) and NPLOC4/TSPAN10 (17q25.3). Three of these loci also demonstrated genome-wide signifi-
cant association with refractive astigmatism: LINC00340, HERC2/OCA2 and NPLOC4/TSPAN10. The genetic correlation 
between corneal and refractive astigmatism was 0.85 (standard error = 0.068, P = 1.37 × 10−35). Here, we have undertaken 
the largest genome-wide association studies for corneal and refractive astigmatism to date and identified four novel loci for 
corneal astigmatism, two of which were also novel loci for refractive astigmatism. These loci have previously demonstrated 
association with axial length (ZC3H11B), myopia (NPLOC4), spherical equivalent refractive error (LINC00340) and eye 
colour (HERC2). The shared role of these novel candidate genes for astigmatism lends further support to the shared genetic 
susceptibility of myopia and astigmatism.
Introduction
Astigmatism occurs when the eye fails to bring light from 
a point source object to a single point focus on the retina, 
resulting in impaired vision. If uncorrected in childhood, 
astigmatism is a risk factor for amblyopia development 
(Read et al. 2007; Harvey 2009). In the human eye, the 
two major sources of astigmatism are the cornea and the 
crystalline lens. Astigmatism can be described as either 
“refractive”, which encompasses all contributing sources, 
or “corneal”, which is restricted to the corneal component, 
the major contributing source in most cases of moderate and 
high astigmatism (Read et al. 2007).
Family- and twin-based studies have previously reported 
that genetic factors make a notable contribution to the devel-
opment of corneal and refractive astigmatism, with the 
proportion of trait variance attributable to genetic effects 
(heritability) estimated at 50–65% (Hammond et al. 2001; 
Kim et al. 2013; Dirani et al. 2006; Clementi et al. 1998; 
Grjibovski et al. 2006). Genome-wide association stud-
ies (GWAS) for refractive astigmatism and corneal astig-
matism have identified a single locus for each; in the pro-
moter of PDGFRA (4q12) for corneal astigmatism (Fan 
et al. 2011; Guggenheim et al. 2013; Shah et al. 2018) and 
near NRXN1 (2p16.3) for refractive astigmatism (Li et al. 
2015). Additional loci demonstrating suggestive association 
(P < 1 × 10−5) for refractive astigmatism have been identi-
fied near the genes VAX2, TOX and LINC00340 (Li et al. 
2015; Lopes et al. 2013). In contrast, more than a hundred 
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markers have shown genome-wide significant association 
(P < 5 × 10−8) for the highly heritable refractive traits spheri-
cal equivalent and myopia in GWAS studies (Kiefer et al. 
2013; Pickrell et al. 2016; Verhoeven et al. 2013; Tedja et al. 
2018).
This paucity of genome-wide significant markers iden-
tified in GWAS for astigmatism may be due to any of the 
following reasons. Firstly, limitations of the approach used 
to define astigmatism in previous studies, such as the use 
of an arbitrary threshold for assigning case/control status. 
Secondly, the effects of age may not have been taken into 
account fully, since changes in both the prevalence and 
direction (axis) of astigmatism occur across the lifespan 
(Sanfilippo et al. 2015; Schuster et al. 2017). Thirdly, there 
may be a major role for rare variants, i.e. risk alleles with 
a minor allele frequency (MAF) < 1%, which are typically 
excluded from GWAS analyses, and fourthly, the causal 
markers may have extremely small effect sizes, thus ren-
dering previous studies underpowered to detect associated 
markers because of their insufficient sample size. The larg-
est study published to date was a GWAS meta-analysis for 
refractive astigmatism performed by Li et al. (2015), which 
had a sample of 45,931 individuals, including 36,636 indi-
viduals of European ancestry and 9295 individuals of Asian 
ancestry.
The availability of genotype data for the UK Biobank 
cohort, approximately 23% of whom had data on corneal 
and/or refractive astigmatism from non-cycloplegic autore-
fraction, provided an opportunity to identify genetic markers 
associated with corneal or refractive astigmatism using a 
comprehensive approach and at a larger scale than had been 
possible previously.
Methods
UK biobank sample
UK Biobank is a large prospective study following the health 
and wellbeing of approximately 500,000 participants resi-
dent in the UK aged between 40 and 69 years-old at the base-
line recruitment visit (during the period 2006–2010). UK 
Biobank received ethical approval from the NHS Research 
Ethics Committee (Reference: 11/NW/0382). Baseline 
assessment was undertaken at 1 of 22 assessment centres 
distributed across the UK (Allen et al. 2014; Sudlow et al. 
2015). Approximately 20,000 participants also attended 
the first repeat assessment visit (during the period 2012 to 
2013). Demographic information and medical history were 
ascertained through touch-screen questionnaires. Partici-
pants also underwent a wide range of physical and cogni-
tive assessments, including blood sampling (for DNA) and, 
for participants recruited towards the end of the recruitment 
period, an ophthalmic examination. Phenotyping, genotyp-
ing and imputation were carried out by members of the UK 
Biobank team.
Phenotypes
119,806 participants had keratometry readings taken for 
at least 1 eye using the Tomey RC 5000 autorefractor-
keratometer (Tomey Corp., Nagoya, Japan). Up to 6 meas-
urements were taken for each eye using 6-mm diameter 
keratometry mires, from which corneal astigmatism was 
derived (see below). 130,521 participants had non-cyclo-
plegic autorefraction performed for at least one eye using 
the same auto autorefractor-keratometer, with up to ten 
measurements taken for each eye. In all instances, par-
ticipants were required to remove contact lenses, if worn. 
Refractive astigmatism was derived from the autorefrac-
tion cylindrical power. Spherical equivalent was recorded 
as the spherical power plus half of the cylindrical power 
from autorefraction. All keratometry/autorefractor meas-
urements flagged with an error code “E” (indicating 
“Lower reliability data”) were recoded as missing before 
taking the mean trait values for each eye individually 
across assessment centre visits, then the mean of both 
eyes for each individual. The mean corneal astigmatism 
and mean refractive astigmatism for each individual were 
also categorised as dichotomous variables using a grid 
of thresholds to define case/control status, from 0.50 to 
1.50 D, in 0.25 D steps. After the exclusion of unreliable 
readings, 119,799 participants had measures for corneal 
astigmatism, and 130,459 participants had measures for 
refractive astigmatism and spherical equivalent refractive 
error.
Genotyping and imputation
Participant DNA samples were genotyped by UK Biobank 
researchers at approximately 800,000 genetic markers 
using one of two genotyping arrays, the UK BiLEVE 
Axiom array or the UK Biobank Axiom array. Genetic data 
were released in two waves. In the UK Biobank “Interim 
150K” release, data were made available for 152,725 
samples imputed at 72,355,689 markers using IMPUTE2 
(Howie et al. 2011) with a merged 1000 Genomes Project 
Phase 3 and UK10K Project haplotype reference panel 
(Davies et al. 2016; Wain et al. 2015). Further details 
of the imputation protocol can be found at http://bioba 
nk.ctsu.ox.ac.uk/cryst al/refer .cgi?id=15702 0. As detailed 
below, of these 152,725 genotyped participants, 141,751 
were of European ancestry based on principal components 
analysis (PCA), and were non-outliers for heterozygosity. 
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Data from this UK Biobank “Interim 150K” release were 
used for SNP-heritability estimation.
The PCA for data from participants in the “Interim 
150K” release was carried out as follows. Following Abra-
ham and Inouye (2014), genotype data for 1397 individu-
als from release #3 of phase 3 of the HapMap project were 
downloaded, and related individuals were excluded based 
on the pedigree file “relationships_w_pops_041510.txt”. 
For each HapMap3 ancestry group separately, SNPs with 
minor allele frequency (MAF) < 1%, missingness > 1%, 
Hardy–Weinberg equilibrium (HWE) P < 5 × 10E−6 and 
non-autosomal variants were removed, as were individuals 
with missingness > 1%, and genomic regions of high link-
age disequilibrium (LD) and/or known inversions (chr5: 
44–51.5 Mb, chr6: 25–33.5 Mb, chr8: 8–12 Mb, chr11: 
45–57 Mb). The remaining SNPs were intersected with 
those included on the two genotyping arrays used by UK 
Biobank (as listed in the files, “Axiom_UKB_WCSG.na34.
annot2.csv” and “Axiom_UKBiLEVE.na34.annot.csv” 
from the Affymetrix website) and LD-pruned (Chang et al. 
2015) using the Plink 1.9 command—indep-pairwise 1000 
10 0.1, resulting in a set of 56,401 common, successfully 
genotyped variants in HWE and low LD present in both 
UK Biobank and HapMap3. With the genotype data for 
these SNPs, principal components analysis was carried 
out for 1114 unrelated HapMap3 individuals who clustered 
according to their assigned ancestry, using the smartpca 
program from the Eigensoft package (Price et al. 2006). 
PCAs were projected onto UK Biobank participants and 
individuals of European ancestry were defined as lying 
within four standard deviations of the mean for the first 
20 PCs. Of the 152,729 individuals included in the UK 
Biobank genetic data interim release, 142,126 (93.1%) 
were identified as having European ancestry. Excluding 
heterozygosity outliers (defined as lying outside the mean 
±4 standard deviation heterozygosity range) from this 
European ancestry sample left 141,751 individuals.
The second wave (July 2017 release) of genetic data 
released from the UK Biobank consisted of imputed geno-
type information for all 488,377 participants whose data 
passed quality control filters (Bycroft et al. 2017). This 
release of genetic data included all available individuals 
from the “Interim 150K” data release. Briefly, imputation 
was carried out by Bycroft et al. (2017) using IMPUTE4, 
an updated version of IMPUTE2 (Howie et  al. 2011; 
Bycroft et al. 2017) with a reference panel comprising of 
the Haplotype Reference Consortium (HRC) and a merged 
1000 Genomes Project Phase 3 and UK10K Project hap-
lotype reference panel (Bycroft et al. 2017; McCarthy 
et al. 2016; The UK 10K Consortium et al. 2015). Due 
to uncertainty about the reliability of the 1000 Genomes 
and UK10K imputations, for the present work only the 
~ 40 million markers present in the HRC imputation panel 
were utilised. All markers were mapped to NCBI human 
genome build 37 (hg19/GRCh37) coordinates.
Of the 488,377 genotyped participants, 409,728 were 
classified as a “White British-ancestry subset” by Bycroft 
et al. (2017). These 409,728 individuals self-reported White 
British ethnicity and clustered together with other individu-
als of White British-ancestry in a PCA analysis (Bycroft 
et al. 2017). After excluding heterozygosity outliers (het-
erozygosity within four standard deviations of the mean of 
the White British-ancestry subset) data for these individuals 
from the second wave of genetic data (July 2017 release) 
were used for the GWAS analyses.
Exclusion criteria
To minimise the effects of ocular pathology or surgery 
affecting keratometry/autorefraction readings, individu-
als were excluded from analyses if at any visit, they self-
reported having had any injury or trauma resulting in loss 
of vision, cataract extraction/lens implant, surgery for glau-
coma or high eye-pressure or trabeculectomy, refractive laser 
eye surgery, corneal graft surgery, or any eye surgery in the 
last four weeks. Individuals responding “Don’t know” to 
the latter four questions were also excluded. For analyses of 
refractive astigmatism, individuals were further excluded if 
they self-reported having had: cataract or “other serious eye 
condition”, any eye surgery or retinal operation/vitrectomy. 
The UK Biobank study did not include specific questions 
regarding contact lens wear, thus individuals could not be 
excluded from analyses for reasons pertaining to the wear of 
specific contact lens types such as orthokeratology lenses. 
However, orthokeratology lenswear in the 40–70 year age 
group is rare in the UK (Morgan 2007). Individuals whose 
self-reported and genetically inferred sex differed were also 
omitted from the analyses.
“High‑confidence” markers
For the mixed model analyses carried out using BOLT and 
GCTA (see below) a set of approximately 890,000 “high-
confidence” markers in weak LD was generated using 
PLINK 2.0 (Purcell et al. 2007; Chang et al. 2015). All 
markers with an “rs” prefix that were directly genotyped or 
imputed in at least 99% of individuals, with MAF > 0.005 
and imputation quality (INFO) > 0.90 were LD-pruned 
(using the command–indep-pairwise 50 5 0.1) to obtain 
list of markers for creating genetic relationship matrices 
(GRMs). Of these “high-confidence” markers, approxi-
mately 23% had been directly genotyped.
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SNP‑heritability estimation
Using the “high-confidence” markers, the PLINK 1.9 com-
mand—make-grm-bin—was used to create separate GRMs 
for the analysis of corneal astigmatism and the refractive 
phenotypes (refractive astigmatism and spherical equiva-
lent). All individuals in the “Interim 150K” release data-
set who, after exclusions, had information available for the 
respective phenotype were included in the initial GRMs, 
which were subsequently restricted to unrelated individuals 
based on a pairwise relatedness threshold of 0.025 (approx-
imately equivalent to third degree relatives) (Yang et al. 
2011b). If pairs of individuals had a relatedness coefficient 
greater than this cut-off, one individual from this pair was 
removed. The final GRMs for corneal astigmatism and for 
the two refractive phenotypes had sample sizes of 27,737 
and 28,403 unrelated individuals, respectively. SNP-her-
itability (h2SNP) estimates were obtained using the default 
additive effects model in GCTA (Yang et al. 2011a). Corneal 
astigmatism, refractive astigmatism and spherical equiva-
lent were considered as continuous traits, or as dichotomous 
traits defined using each of the different case thresholds 
examined (0.50 D–1.50 D, in 0.25 D steps for corneal and 
refractive astigmatism; and − 0.50 D to − 1.50 D, in 0.25 D 
steps for spherical equivalent). For dichotomous traits, trans-
formation to the liability scale was performed by GCTA, 
as described by Lee et al. (2011). Approximate population 
prevalence estimates were obtained from the full sample of 
UK Biobank individuals with valid phenotype measures, 
irrespective of ancestry or exclusion criteria.
Additional SNP-heritability estimates were obtained in 
an attempt to partition SNP-heritability into separate addi-
tive and dominance components. GCTA-GREMLd (Zhu 
et al. 2015) was used to generate additive and dominance 
GRMs for corneal astigmatism and the refractive pheno-
types using the same unrelated individuals as used previ-
ously (N = 27,737 and 28,403 respectively). Both additive 
and dominance GRMs for each trait were included in a joint 
GCTA analysis to ascertain the partitioned contributions of 
additive and dominance effects to the respective phenotypic 
variances. All traits were coded as continuous variables for 
these GREMLd analyses.
Genome‑wide association studies (GWAS)
Genome-wide single marker association tests were under-
taken for corneal astigmatism (N = 86,335) and for refrac-
tive astigmatism (N = 88,005) using individuals with genetic 
data made available in the UK Biobank second data release 
(July 2017 release). Corneal and refractive astigmatism were 
considered as continuous traits using the standard “infinitesi-
mal” mixed linear model approach implemented in BOLT-
LMM v2.3. In BOLT-LMM, GRMs constructed using the 
“high-confidence” markers were used to account for residual 
population structure and cryptic relatedness (Yang et al. 
2014; Loh et al. 2015, 2018); therefore, related individuals 
were not excluded from the BOLT-LMM analyses. Regional 
association plots for genome-wide significant loci were 
created using LocusZoom (Pruim et al. 2010). Sensitivity 
analyses were performed using PLINK 2.0, with corneal and 
refractive astigmatism considered as continuous traits (as in 
BOLT-LMM analyses) and then by classifying astigmatism 
as a dichotomous trait using a threshold value of astigmatism 
≥ 1.00 D to define case status. As PLINK 2.0 used linear/
logistic regression methods to run association analyses, 
these tests were restricted to unrelated individuals. A pair-
wise relatedness threshold of 0.025 was applied to remove 
one of each pair of related individuals from these PLINK 
2.0 analyses. For all GWAS analyses, participants’ spherical 
equivalent refractive error and age at the assessment visit 
were included as quantitative covariates (using average val-
ues for participants who attended more than one visit). Gen-
otyping array (UK BiLEVE or UK Biobank) and sex (female 
or male) were included as discrete covariates. Following Fan 
et al. (2016), markers with missingness > 0.01, MAF < 0.01, 
HWE test P value < 1 × 10−6 or INFO < 0.4 were excluded, 
along with samples with missingness > 0.05.
For loci achieving the genome-wide significance thresh-
old of P < 5 × 10−8, previously identified associations with 
other ocular traits were identified via the NHGRI-EBI cata-
logue of published genome-wide association studies (Mac-
Arthur et al. 2017).
Conditional analysis
To ascertain whether loci achieving genome-wide signifi-
cant association were driven by a single causal marker or by 
multiple causal markers in the region, conditional analysis 
was performed using GCTA-COJO (Yang et al. 2012). The 
marker demonstrating the strongest degree of association at 
a genome-wide significant locus was included as a covariate 
in the association test model and the association analysis 
repeated for all markers within ± 1000 kb of this marker. 
The association signals obtained in the conditional analysis 
will be greatly diminished compared to the original analy-
sis in the event of there being only a single causal locus. In 
the presence of multiple causal markers at a locus, mark-
ers tagging additional causal markers, independent of the 
conditioned marker will continue to demonstrate significant 
association in the GCTA-COJO analysis.
Genomic inflation of GWAS summary statistics
The genomic inflation factor (λGC) was determined by divid-
ing the median observed χ2 test statistic by 0.456 (Devlin 
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et  al. 2001). However, since λGC determined using this 
method can be overly conservative in cases of true poly-
genicity (Bulik-Sullivan et al. 2015b), we also calculated 
the intercept from an LD Score (LDSC) regression analy-
sis, using European ancestry individuals from the 1000 
Genomes Project for the reference LD scores, as described 
by Bulik-Sullivan et al. (2015b).
Genetic effect sizes in male vs. female participants
To test for a gender-related difference in effect size for the 
lead variants associated with corneal astigmatism and refrac-
tive astigmatism in the GWAS analyses, linear regression 
analyses were carried out separately in males and females 
for astigmatism coded as a continuous trait. The genetic 
effect sizes (beta coefficients for the SNP effect from the 
regression analyses) were then compared between males and 
females, as described by Winkler et al. (2014). The sex-
specific linear regression analyses were carried out using 
the same set of White British unrelated individuals as for 
the PLINK 2.0 analyses of astigmatism described above. 
Age, spherical equivalent refractive error, and a binary indi-
cator for genotyping array were included as covariates. To 
account for multiple testing (7 variants tested in total), a P 
value < 0.05/7 = 0.007 was taken as the threshold for declar-
ing a difference in effect size between males and females.
Gene‑based and gene‑set tests
Gene-based and gene-set tests were performed using the 
summary statistics results from GWAS in MAGMA v1.06 
(de Leeuw et al. 2015). Genes were defined according to 
NCBI build 37 (hg19/GRCh37) coordinates, with the inclu-
sion of a 50 kb flanking region added to the transcription 
start/stop positions. These flanking regions were added to 
genomic regions as polymorphisms in these 5′ and 3′ regions 
often influence gene regulation and expression not only for 
the nearest gene but for other nearby genes too (Corradin 
et al. 2016; Guo and Jamison 2005; Brodie et al. 2016; 
Schork et al. 2013). MAGMA estimates LD patterns for each 
gene using an ancestry-matched reference file; specifically 
the reference files composed of data for the 503 unrelated 
individuals of European ancestry from Phase 3 of the 1000 
Genomes Project. For the gene-based tests, multiple test-
ing was accounted for by applying a false discovery rate 
threshold of 5%.
Gene-set tests in MAGMA were performed using a “com-
petitive” approach whereby the test statistics for all genes 
within a particular gene-set (e.g. a biological pathway) were 
combined to obtain a joint association statistic. This statistic 
was compared against that for all other genes not in that set 
whilst accounting for the number of SNPs within each gene, 
gene density and differential sample size (unequal sample 
size contributing to each gene) (de Leeuw et  al. 2015, 
2016). Gene-sets were defined using the Molecular Signa-
tures Database (MSigDB) (Subramanian et al. 2005). Gene 
definitions and their respective association signals for genes 
contributing to gene-sets were taken from the MAGMA 
gene-based analyses with the aim of identifying potential 
biological processes that may be influenced by these mark-
ers. Multiple testing was accounted for by applying a false 
discovery rate threshold of 5%.
SNP‑heritability and genetic correlation analyses 
using GWAS summary statistics
Using LDSC (Bulik-Sullivan et al. 2015a, b), SNP-heritabil-
ities of corneal astigmatism and refractive astigmatism were 
quantified using summary statistics from the single marker 
association tests conducted using BOLT-LMM. Genetic cor-
relations between pairs of the three refractive error traits: 
corneal astigmatism, refractive astigmatism and spherical 
equivalent were also quantified using this method. Summary 
statistics for spherical equivalent were obtained from single 
marker association tests conducted using BOLT-LMM for 
the same variants and individuals as performed for refrac-
tive astigmatism. In all instances, the reference LD scores 
used were the same as those utilised when calculating the 
intercepts during LD Score regression analyses.
Phenotypic correlation
Pearson correlation coefficients were calculated for all 
unrelated individuals included in the single marker GWAS 
analyses who had data available for all refractive error traits 
investigated (i.e. corneal astigmatism, refractive astigmatism 
and spherical equivalent; N = 63,466).
Results
Participant demographics
Analyses were carried out in a sample of UK Biobank par-
ticipants with a mean age of 58.2 years (standard deviation: 
7.9 years; 25th and 75th percentiles: 52.25 and 64.50 years) 
of White British/European ancestry, based on genetic princi-
pal components analysis. Approximately 54% of the sample 
were female, and the mean spherical equivalent refractive 
error was − 0.29 D (standard deviation: 2.72 D; 25th and 
75th percentiles: − 1.23 and + 1.13 D). Approximately 4.0% 
of the participants had high myopia (defined as a refractive 
error averaged between the two eyes ≤ − 6.00 D) and 18.0% 
of the sample had anisometropia of at least 1.00 D. The level 
of corneal astigmatism was relatively constant across the age 
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spectrum of the participants, while the level of refractive 
astigmatism increased with age (Online Resource 1). Full 
details of the refractive error and demographic characteris-
tics of the participants have been reported by Cumberland 
et al. (2015).
Determining optimal trait definitions based 
on SNP‑heritability
Astigmatism has often been analysed as a dichotomous trait 
in genetic studies; however, the choice of the threshold used 
to define case/control status has varied from study to study 
(Fan et al. 2011; Vitale et al. 2008; Li et al. 2015; Hammond 
et al. 2001; Dirani et al. 2010; Quek et al. 2004; He et al. 
2004; Huynh et al. 2007; Shah et al. 2018). In an attempt 
to determine an optimal trait definition for detecting com-
monly occurring genetic markers with additive effects on 
astigmatism, we calculated SNP-heritability estimates with 
GCTA for corneal astigmatism and refractive astigmatism 
(and, for comparison, spherical equivalent) classified either 
as continuous or dichotomous traits, and using a grid of case 
thresholds for the latter (namely, 0.50, 0.75, 1.00, 1.25 and 
1.50 D of astigmatism; or − 0.50, − 0.75, − 1.00, − 1.25 and 
− 1.50 D of spherical equivalent). Following previous prec-
edents (Schulze and McMahon 2004; Corvin et al. 2010; 
Koran et al. 2014), this approach was predicated on the 
assumption that the trait definition capturing the greatest 
SNP-heritability would be the one most likely to highlight 
genome-wide significant loci in subsequent GWAS of these 
traits.
For corneal astigmatism, SNP-heritability was greatest 
using a case-definition threshold of 0.50 D (h2SNP = 0.094) 
and negligible for a case threshold of 1.50 D (Fig. 1, Online 
Resource 2). However, there appeared to be no statistically 
meaningful difference in SNP-heritability across the range 
of trait definitions tested since all of the standard errors over-
lapped (Fig. 1). For refractive astigmatism, SNP-heritabil-
ity estimates were generally higher than those for corneal 
astigmatism (h2SNP: 0.015–0.158; Fig. 1, Online Resource 
2). Using case-definition thresholds of increasing magni-
tude between 0.50 D and 1.25 D inclusive yielded increas-
ing SNP-heritability estimates, although the overlapping 
standard errors meant that, again, there was no statistical 
support for meaningful differences across the range of case 
thresholds tested. SNP-heritability estimates for spherical 
equivalent refractive error were much larger than those for 
the astigmatism traits (h2SNP: 0.462–0.491; Fig. 1, Online 
Resource 2).
When astigmatism and spherical equivalent were mod-
elled as continuous traits, the estimates of SNP-heritability 
were numerically lower, but with much narrower standard 
errors, compared to when they were modelled as dichoto-
mous traits: continuous trait h2SNP (SE): corneal astigma-
tism = 0.061 (0.021); refractive astigmatism = 0.046 (0.020); 
spherical equivalent = 0.387 (0.022) (Fig. 1). However, once 
again, these numerical differences in SNP-heritability esti-
mated using dichotomous vs. continuous trait definitions 
were not large enough to attain statistical support. Domi-
nance effects, investigated using GREMLd, were found to 
make a negligible contribution to the heritability of all three 
traits (Online Resource 3).
In light of these findings, we elected to model astigma-
tism as a continuous trait for our primary GWAS analyses, 
with follow-up sensitivity analyses using a mid-range case-
definition threshold of 1.00 D, which is also the threshold 
most commonly adopted in the clinical literature.
Genome‑wide association studies (GWAS)
After restricting the analysis sample to individuals of White 
British-ancestry and applying exclusions for eye disorders 
with the potential to alter the level of astigmatism, there 
were 86,355 individuals available for inclusion in the GWAS 
for corneal astigmatism and 88,005 individuals in the GWAS 
for refractive astigmatism. After applying marker restric-
tions, there were 5,901,671 and 5,900,115 markers avail-
able for inclusion in the corneal and refractive astigmatism 
GWAS analyses, respectively.
For our primary analyses, we carried out single marker 
association tests using the mixed linear model approach 
implemented in BOLT-LMM, since this provides greater 
power than tests using standard linear regression (Yang et al. 
2014). GWAS analyses identified 89 and 45 markers achiev-
ing genome-wide significant association (P < 5 × 10−8) for 
corneal astigmatism and refractive astigmatism, respectively 
(Online Resource 4). Specifically, for corneal astigmatism, 
genome-wide significant markers clustered in four regions 
(Figs. 2, 3), while for refractive astigmatism, they clustered 
in three regions (Figs. 2, 3).
For corneal astigmatism, the nearest gene at each of 
the four genome-wide significant loci was ZC3H11B (top 
Fig. 1  Estimates of SNP-heritability (h2SNP) using GCTA. Error bars 
represent the standard error of the h2SNP estimate
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marker: rs12032649, P = 5.00 × 10−14), LINC00340 (top 
marker: rs196052, P = 7.80 × 10−11), HERC2 (top marker: 
rs1129038, P = 1.10 × 10−15) and TSPAN10/NPLOC4 (top 
marker: rs62075722, P = 2.20 × 10−13) (Table 1). None of 
these loci have previously shown genome-wide significant 
association with corneal or refractive astigmatism. At the 
only previously identified genome-wide significant locus for 
corneal astigmatism, the promoter region of the PDGFRA 
gene at 4q12, the marker demonstrating strongest associa-
tion was rs4864857 (P = 1.20 × 10−6). Conditional analyses 
carried out by conditioning on the top marker at each of the 
four novel genome-wide significant loci suggested that these 
four association signals were each driven by a single causal 
marker (Online Resource 5). However, the strength of the 
association signal at the HERC2 locus when conditioning on 
top marker rs1129038 did yield a suggestive association sig-
nal within the adjacent OCA2 gene (top marker: rs1800407, 
P = 9.88 × 10−6).
As mentioned above, for refractive astigmatism, mark-
ers achieving genome-wide significant association clus-
tered in three regions (Table 2): LINC00340, (top marker: 
rs12196123, P = 1.60 × 10−15), HERC2 (top marker: 
rs1129038, P = 2.30 × 10−11) and TSPAN10/NPLOC4 (top 
marker: rs34635363, P = 2.00 × 10−9). Notably, all of these 
loci also demonstrated significant association with corneal 
astigmatism. Conditional analyses for these genome-wide 
significant loci also suggested these association signals 
were each driven by a single causal marker with the excep-
tion of the association signal at HERC2 which appeared 
to be driven by an additional independent causal marker 
within the OCA2 gene at rs1800407 (P = 9.03 × 10−15) 
(Online Resource 6). Conditioning on both rs1129038 and 
rs1800407 at the HERC2-OCA2 locus resulted in a sugges-
tive association signal at rs7497044 (P = 1.90 × 10−6), an 
intronic variant within the nearby GABRG3 gene. In a pre-
vious meta-analysis of GWAS for corneal curvature in Euro-
pean ancestry cohorts from Australia (Mishra et al. 2012), 
Fig. 2  Manhattan and Quantile–Quantile plots for GWAS of corneal 
astigmatism and refractive astigmatism using BOLT-LMM. a, b Cor-
neal astigmatism; c and d refractive astigmatism. Manhattan plots 
(a, c): upper  horizontal line indicates the genome-wide significance 
threshold at P = 5 × 10−8; lower horizontal line indicates P = 1 × 10−5. 
Quantile–Quantile plots (b, d): Y-axis shows observed negative  log10 
p values and X-axis shows expected negative  log10 p values according 
to the null hypothesis of no genetic association. Diagonal  line = line 
of unity (observed = expected)
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Fig. 3  Regional association 
plots for loci demonstrat-
ing genome-wide significant 
association (P < 5 × 10−8) in 
GWAS for Corneal Astigma-
tism and Refractive Astig-
matism using BOLT-LMM. 
a–d Corneal astigmatism; e–g 
refractive astigmatism. In order 
of chromosome: a rs12032649, 
b rs196052, c rs1129038, d 
rs62075722, e rs12196123, f 
rs1129038, and g rs34635363. 
Symbol shading denotes linkage 
disequilibrium (r2) values of 
variants with respect to the lead 
marker (named and high-
lighted). NB: rs14879552 is a 
synonym for rs12032649
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marker rs17137734 within GABRG3 achieved suggestive 
association (P = 9 × 10−6). Pairwise LD between markers 
rs7497044, rs17137734, rs1129038 and rs1800407 varies 
from low to negligible in Europeans (r2 = 0.0–0.1).
Genomic inflation factors (λGC) were 1.094 for corneal 
astigmatism and 1.045 for refractive astigmatism; however, 
when accounting for the polygenic nature of these respective 
traits using the intercepts from LD Score regression (λLDSC), 
inflation due to uncorrected population effects was estimated 
to be considerably lower for both traits (λLDSC = 1.023 and 
1.005 for corneal and refractive astigmatism, respectively).
As validation for the use of mixed linear models to con-
duct the association tests, analyses were repeated using 
linear regression (implemented in PLINK 2.0) and an iden-
tical set of covariates (note that this approach necessitated 
the analysis of a smaller sample of unrelated individuals). 
For corneal astigmatism, all four loci identified using the 
mixed linear model analysis also demonstrated genome-
wide significant association using the linear regression 
model in PLINK, while only two of the three loci origi-
nally associated with refractive astigmatism (LINC00340 
and HERC2) continued to demonstrate genome-wide 
significant association (Online Resources 7, 8, 11a, 11c, 
12a and 12c). Additional sensitivity analyses were per-
formed using logistic regression for the same groups of 
individuals and covariates as analysed by linear regression, 
with cases defined as individuals with corneal or refrac-
tive astigmatism ≥ 1.00 D. Here, three of the four previ-
ously identified loci, near the genes ZC3H11B, HERC2 
and TSPAN10/NPLOC4, demonstrated genome-wide 
Table 1  Markers achieving association test P values < 1 × 10−5 in GWAS for Corneal astigmatism analysed as a continuous trait with BOLT-
LMM
EAF effect allele frequency, HWE P value P value from the Hardy–Weinberg disequilibrium test, SE standard error, NB markers within ± 500 kb 
of listed (lead) marker are not included in this list
Marker Chromosome Position Effect allele Other allele EAF HWE P value Effect (SE) P value Nearest gene
rs1129038 15 28,356,859 C T 0.215 0.621 − 0.028 (0.003) 1.10 × 10−15 HERC2
rs12032649 1 219,778,959 T G 0.614 0.138 − 0.022 (0.003) 5.00 × 10−14 ZC3H11B
rs62075722 17 79,611,271 A G 0.358 0.594 0.022 (0.003) 2.20 × 10−13 TSPAN10
rs196052 6 22,057,200 T A 0.622 0.477 0.019 (0.003) 7.80 × 10−11 LINC00340
rs61935843 12 116,617,757 C A 0.918 0.873 0.028 (0.005) 1.00 × 10−7 MED13L
rs1579050 2 153,364,527 A G 0.425 0.017 0.015 (0.003) 3.00 × 10−7 FMNL2
rs10993820 9 136,707,730 A G 0.791 0.803 − 0.018 (0.003) 4.20 × 10−7 VAV2
rs9517490 13 99,584,305 T C 0.300 0.703 0.015 (0.003) 6.80 × 10−7 DOCK9
rs1353386 4 81,947,080 A C 0.148 0.808 0.019 (0.004) 1.00 × 10−6 BMP3
rs7931326 11 130,276,347 C G 0.935 0.716 − 0.028 (0.006) 1.10 × 10−6 ADAMTS8
rs4864857 4 55,089,814 T C 0.784 0.166 − 0.017 (0.003) 1.20 × 10−6 PGDFRA
rs112947941 12 6,997,808 A G 0.931 0.074 0.028 (0.006) 1.20 × 10−6 DSTNP2
rs12473604 2 232,401,893 G A 0.775 0.258 − 0.016 (0.003) 1.50 × 10−6 NMUR1
rs35313216 11 66,224,195 G A 0.928 0.304 0.026 (0.005) 2.20 × 10−6 LOC100505524
rs11084579 19 31,802,723 G A 0.666 0.270 0.014 (0.003) 2.20 × 10−6 TSHZ3
rs10279904 7 36,806,587 C T 0.987 0.363 − 0.058 (0.0012) 2.20 × 10−6 AOAH
rs138016380 10 34,449,466 C A 0.976 0.821 − 0.044 (0.009) 2.40 × 10−6 PARD3
rs11639295 15 67,460,757 C T 0.706 0.902 0.015 (0.003) 2.70 × 10−6 SMAD3
rs16971637 16 19,155,288 A C 0.959 0.931 − 0.033 (0.007) 3.00 × 10−6 ITPRIPL2
rs117023057 7 158,823,501 G A 0.984 0.092 − 0.054 (0.012) 3.20 × 10−6 VIPR2
rs2445565 11 86,803,194 G C 0.470 0.119 − 0.013 (0.003) 4.20 × 10−6 TMEM135
rs12551905 9 7,760,772 T C 0.985 0.908 − 0.054 (0.012) 4.50 × 10−6 C9orf123
rs149846728 8 36,770,379 G A 0.949 0.332 0.030 (0.006) 5.40 × 10−6 KCNU1
rs62169220 2 145,225,071 A G 0.850 0.354 − 0.018 (0.004) 5.80 × 10−6 ZEB2
rs830557 5 67,608,743 C T 0.529 0.368 0.013 (0.003) 6.50 × 10−6 PIK3R1
rs56274409 14 96,690,828 A T 0.944 0.567 − 0.028 (0.006) 7.20 × 10−6 BDKRB2
rs6741982 2 117,793,229 A G 0.961 0.748 − 0.033 (0.007) 8.70 × 10−6 MTND2P21
rs6536686 4 163,731,498 C T 0.192 0.921 0.016 (0.004) 8.80 × 10−6 MIR4454
rs57770499 19 36,260,996 G A 0.820 0.808 − 0.016 (0.004) 1.00 × 10−5 C19orf55
rs13181991 5 146,163,470 C T 0.917 0.327 0.023 (0.005) 1.00 × 10−5 PPP2R2B
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significant association for corneal astigmatism, while only 
the LINC00340 locus continued to demonstrate genome-
wide significant association for refractive astigmatism 
(Online Resources 9, 10, 11b, 11d, 12b and 12d). In all 
instances, the association signals were reduced using lin-
ear and logistic regression compared to the mixed linear 
model analyses. This was likely due to the substantial drop 
in sample size necessitated by standard regression-based 
methods, which cannot account for relatedness between 
individuals. Tests for a difference in genetic effect size in 
male vs. female participants for the genome-wide signifi-
cant loci for corneal astigmatism and refractive astigma-
tism did not identify any such differences after accounting 
for multiple testing (Online Resources 13 and 14), suggest-
ing that the newly identified variants confer susceptibility 
to astigmatism in both sexes.
Table 2  Markers achieving association test-P values < 1 × 10−5 in GWAS for refractive astigmatism analysed as a continuous trait with BOLT-
LMM
EAF effect allele frequency, HWE P value P value from the Hardy–Weinberg disequilibrium test, SE standard error, NB markers within ± 500 kb 
of listed (lead) marker are not included in this list
Marker Chromosome Position Effect allele Refer-
ence 
allele
EAF HWE P value Effect (SE) P value Nearest gene
rs12196123 6 22,082,263 C T 0.443 0.659 − 0.023 (0.003) 1.60 × 10−15 LINC00340
rs1129038 15 28,356,859 C T 0.215 0.047 − 0.023 (0.004) 2.30 × 10−11 HERC2
rs34635363 17 79,549,250 G A 0.641 0.759 − 0.018 (0.003) 2.00 × 10−9 NPLOC4
rs10177414 2 228,211,470 T C 0.598 0.020 − 0.015 (0.003) 1.60 × 10−7 MFF
rs6029691 20 40,094,364 C G 0.688 0.621 − 0.016 (0.003) 3.10 × 10−7 CHD6
rs139743 22 25,299,429 A G 0.582 0.675 − 0.015 (0.003) 3.50 × 10−7 SGSM1
rs77008212 2 239,307,113 A G 0.913 0.612 − 0.026 (0.005) 4.70 × 10−7 TRAF3IP1
rs141045115 21 42,387,103 G T 0.971 0.795 − 0.043 (0.009) 6.00 × 10−7 LINC00323
rs10435539 8 109,167,551 G A 0.795 0.051 0.018 (0.004) 6.10 × 10−7 AURKBPS1
rs116771750 1 219,699,050 T C 0.965 0.589 − 0.039 (0.008) 6.70 × 10−7 ZC3H11B
rs79999086 20 1,058,226 T C 0.980 0.245 − 0.051 (0.011) 1.20 × 10−6 LCN1P2
rs17172445 7 55,189,215 G T 0.973 0.687 − 0.043 (0.009) 1.20 × 10−6 EGFR
rs11244084 9 136,191,010 C T 0.926 0.684 − 0.027 (0.005) 1.20 × 10−6 PSMF1
rs115732928 1 214,154,088 A T 0.952 0.115 − 0.033 (0.007) 1.30 × 10−6 PROX1-AS1
rs57717978 6 170,267,973 C T 0.880 0.354 − 0.021 (0.004) 1.60 × 10−6 LOC101929541
rs10494951 1 212,429,259 G A 0.806 0.347 0.018 (0.004) 1.60 × 10−6 LINC00574
rs141720143 9 13,237,186 A C 0.987 0.349 − 0.060 (0.013) 1.70 × 10−6 MPDZ
rs77909168 2 100,555,866 C G 0.985 0.872 − 0.056 (0.012) 2.60 × 10−6 AFF3
rs56288719 8 64,825,393 T C 0.962 0.207 − 0.036 (0.008) 2.70 × 10−6 LOC286184
rs6535231 4 81,951,911 G A 0.041 0.386 0.034 (0.007) 3.40 × 10−6 BMP3
rs192290664 16 82,799,444 A G 0.978 0.410 − 0.046 (0.010) 3.90 × 10−6 CDH13
rs12547340 8 1,149,028 G T 0.790 0.445 0.016 (0.004) 4.00 × 10−6 DLGAP2
rs149069109 16 48,972,368 C T 0.977 0.920 − 0.044 (0.010) 5.20 × 10−6 KLF8P1
rs6434068 2 153,357,541 G C 0.428 0.647 0.013 (0.003) 6.50 × 10−6 FMNL2
rs891933 5 167,591,402 C T 0.537 0.329 0.013 (0.003) 7.30 × 10−6 TENM2
rs116945318 9 21,638,723 A C 0.985 0.779 − 0.055 (0.012) 7.50 × 10−6 KHSRPP1
rs974420 13 93,152,458 G A 0.621 0.012 0.013 (0.003) 8.10 × 10−6 GPC5
rs34314196 8 40,998,854 T A 0.874 0.724 − 0.019 (0.004) 8.20 × 10−6 SFRP1
rs117949737 12 69,299,466 G A 0.974 0.594 0.040 (0.009) 8.30 × 10−6 CPM
rs8104928 19 42,130,284 A G 0.972 0.185 − 0.039 (0.009) 8.40 × 10−6 CEACAM4
rs75819168 17 19,651,119 C G 0.984 0.814 − 0.051 (0.011) 8.50 × 10−6 ALDH3A1
rs117812342 6 108,473,446 A C 0.976 0.766 − 0.042 (0.009) 8.60 × 10−6 OSTM1-AS1
rs55939894 3 7,963,288 A G 0.813 0.845 − 0.016 (0.004) 8.70 × 10−6 LOC101927394
rs513910 13 69,095,822 T C 0.726 0.995 0.014 (0.003) 9.10 × 10−6 RPS3AP52
rs62316885 4 75,558,798 C T 0.962 0.879 − 0.033 (0.008) 1.00 × 10−5 AREGB
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Gene‑based and gene‑set tests
To identify potential candidate genes and biological mech-
anisms enriched with markers attaining low but not nec-
essarily genome-wide significant P values from GWAS, 
gene-based and gene-set tests were performed in MAGMA 
using the results of the mixed linear model analyses. The 
gene-based analysis for corneal astigmatism identified 37 
genes at a false discovery rate (FDR) < 0.05. These genes 
included a cluster of nine genes at the TSPAN10/NPLOC4 
locus (17q25.3; FDR = 2.10 × 10−6) along with the 
genes HERC2 (15q13.1; FDR = 2.30 × 10−4), PDG-
FRA (4q12; FDR = 5.21 × 10−4), and B3GNT7 (2q37.1; 
FDR = 3.66 × 10−3) (Online Resource 15). For refrac-
tive astigmatism, gene-based analysis identified 35 genes 
with FDR < 0.05. Of these genes, seven were clustered 
at the gene-dense TSPAN10/NPLOC4 locus (17q25.3; 
FDR = 5.00 × 10−3). Additional genes identified included 
TMEM211 (22q11.23; FDR = 4.96 × 10−3), PROX1 (1q32.3; 
FDR = 4.96 × 10−3), HERC2 (15q13.1; FDR = 5.00 × 10−3), 
and PLAUR (19q13.31; FDR = 5.69 × 10−3) (Online 
Resource 16). Gene-set analyses in MAGMA yielded non-
significant findings after correction for multiple testing.
SNP‑heritability and genetic correlation analyses 
using GWAS summary statistics
LD Score regression-based SNP-heritability estimates for 
corneal and refractive astigmatism, calculated from the 
GWAS summary statistics for the continuous trait analyses 
described above, were 0.036 (SE = 0.006, P = 4.34 × 10−10) 
and 0.034 (SE = 0.006, P = 2.71 × 10−9), respectively 
(Table 3). These estimates were lower—albeit with overlap-
ping 95% confidence intervals—compared to the equivalent 
estimates obtained directly using GCTA (Table 3).
The phenotypic correlation between each pair of the three 
refractive traits (corneal astigmatism, refractive astigma-
tism and spherical equivalent) were all significantly differ-
ent from the null hypothesis of zero (Table 4). The genetic 
correlation between corneal and refractive astigmatism, cal-
culated using LD Score regression, was 0.85 (SE = 0.068, 
P = 1.37 × 10−35). In contrast, genetic correlations between 
the astigmatism traits and spherical equivalent were weaker 
at −0.108 for corneal astigmatism and spherical equiva-
lent; and − 0.104 for refractive astigmatism and spherical 
equivalent (Table 4). In both of the latter instances, the nega-
tive sign of the genetic correlation is due to the signs of the 
respective traits: astigmatism is always positive, whereas 
spherical equivalent values are negative for myopic individu-
als. Additionally, these genetic correlations were not signifi-
cantly different from zero (P = 0.067 and 0.071, respectively; 
Table 4).
Discussion
The GWAS analyses undertaken here for corneal and refrac-
tive astigmatism are the largest performed to date, and led 
to the discovery of four novel genome-wide significant loci 
associated with corneal astigmatism, and two novel genome-
wide significant loci associated with refractive astigmatism.
Table 3  Estimates of SNP-
heritability (h2SNP) using GCTA 
and LSDC
h2SNP SNP-heritability, SE standard error, P value test of the null hypothesis (h2SNP = 0)
Trait Method No. of markers Sample size h2SNP SE P value
Corneal astigmatism GCTA 732,404 27,707 0.061 0.021 1.19 × 10−3
LDSC 864,048 86,355 0.036 0.006 4.34 × 10−10
Refractive astigmatism GCTA 732,404 28,378 0.046 0.020 7.74 × 10−3
LDSC 863,851 88,005 0.034 0.006 2.71 × 10−9
Table 4  Genetic and phenotypic 
correlations between pairs of 
refractive error traits
Genotypic correlations were obtained using LDSC and summary statistics from BOLT-LMM analyses 
(N = 86,335 or 88,005). All phenotypic correlations are Pearson correlations for 63,466 unrelated individu-
als included in GWAS for these respective traits and with data available for all three refractive error meas-
ures
P values refer to the null hypothesis of zero genetic correlation between traits
CA corneal astigmatism, RA refractive astigmatism, MSE mean spherical equivalent
Trait pairs No. of variants Genetic correlation (SE) P value Phenotypic 
correlation
95% CI
CA and RA 862,521 0.851 (0.068) 1.37 × 10−35 0.615 0.610 to 0.620
CA and MSE 862,524 − 0.108 (0.059) 0.067 − 0.093 − 0.100 to − 0.085
RA and MSE 863,831 − 0.104 (0.057) 0.071 − 0.156 − 0.163 to − 0.148
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The SNP-heritability estimates for corneal and refractive 
astigmatism calculated here were much lower than previous 
broad-sense and narrow-sense heritability estimates from 
twin and family studies (approximately 5% vs. 50%), with 
a negligible contribution of dominance effects. The SNP-
heritability estimates for spherical equivalent calculated here 
were approximately 50% of those obtained from twin stud-
ies (Hammond et al. 2001; Dirani et al. 2006). It should be 
noted that heritability estimation in twin and family studies 
takes into consideration a wider range of sources of genetic 
variation, such as the effects of rare variants and dominance/
epistatic genetic effects; whereas SNP-heritability estimates 
only take account of the additive contribution of commonly 
occurring variants. It should also be noted that both of the 
methods we used to estimate SNP-heritability (GCTA-
GREML and LD score regression) make the assumption 
that the effect sizes of all causal variants conform to a sin-
gle Gaussian distribution, which implies that effect sizes 
are independent of MAF and local LD (Evans et al. 2018). 
Across 19 traits, Speed et al. (2017) found that departure 
from this assumption led to an underestimation of SNP-
heritability by approximately 40%. Nevertheless, the very 
marked reduction in SNP-heritability for the astigmatism 
traits compared to spherical equivalent suggests either a 
major role for rare variants in the development of astigma-
tism and/or that previous heritability estimates were biased 
upwards due to misallocation of environmental effects as 
genetic effects. With regard to spherical equivalent, the 
SNP-heritability estimate obtained here (h2SNP = 0.387; 
P < 1 × 10−10) was similar to a previously published estimate, 
which suggested a SNP-heritability of 0.35 (Guggenheim 
et al. 2015). Importantly, the sample used to generate this 
previous estimate consisted of children aged 7–15 years-old, 
whereas the current investigation utilised a sample of older 
adults (40–69 years old) and heritability estimates are sensi-
tive to population demographics such as age and ethnicity 
(Visscher et al. 2008). To date, no additional estimates of 
SNP-heritability for spherical equivalent, myopia or astig-
matism have been reported in the published literature with 
the exception of conference abstracts (Miyake et al. 2013; 
Hysi et al. 2014).
It could be argued that astigmatism and spherical equiva-
lent refractive error share little genetic susceptibility since 
the genetic correlations between these respective pairs of 
traits were not significantly different from zero. Possible 
explanations for these relatively weak genetic correlations 
are the differences in their respective SNP-heritabilities, 
the number of genome-wide significant associations identi-
fied for each trait, and the fact that spherical equivalent was 
included as a covariate in our GWAS analyses for astigma-
tism. Few commonly occurring markers have demonstrated 
association with astigmatism, yet it is notable that the novel 
loci for corneal and refractive astigmatism identified in our 
GWAS analyses have previously shown association with 
other ocular traits. Table 5 contains a summary of the loci 
achieving genome-wide significant association in our inves-
tigation and previously identified associations of these loci 
with other ocular traits, as reported in the NHGRI-EBI cata-
logue of published genome-wide association studies (Mac-
Arthur et al. 2017). With the exception of the association 
signal at HERC2/OCA2, the majority of the astigmatism sus-
ceptibility loci have demonstrated association with spheri-
cal equivalent-related traits in previous GWAS analyses. 
Furthermore, despite the overlap in genetic variants associ-
ated with spherical refractive error and astigmatism, it is 
noteworthy that the variants most strongly associated with 
each condition appear to be distinct (for example, the vari-
ants consistently found to be most strongly associated with 
spherical refractive error—namely, those at the GJD2 and 
LAMA2 loci—were not amongst the loci most strongly asso-
ciated with corneal astigmatism and refractive astigmatism). 
Therefore, the common variants that confer susceptibility to 
astigmatism appear to comprise only a subset of the wider 
collection of common genetic variants contributing to sus-
ceptibility to spherical equivalent refractive error.
Comparison of the genotypic correlations calculated 
here for UK Biobank participants against those reported 
previously by the CREAM consortium (Shah et al. 2018), 
revealed limited similarity. Specifically, in the UK Biobank 
sample, the genetic correlation between corneal and refrac-
tive astigmatism was higher (0.851 vs. 0.233), that between 
corneal astigmatism and spherical equivalent was similar 
Table 5  Previously observed 
associations with ocular 
traits at the newly identified 
susceptibility loci for corneal 
astigmatism
Gene Region Previous associations References
ZC3H11B 1q41 Axial length
Pathological myopia
Cheng et al. (2013)
Fan et al. (2012)
LINC00340 6p22.3 Refractive astigmatism
Spherical equivalent
Li et al. (2015)
Fan et al. (2016)
HERC2 15q13.1 Eye colour Kayser et al. (2008)
TSPAN10/NPLOC4 17q25.3 Myopia
Advanced age-related macular 
degeneration
Eye colour
Pickrell et al. (2016)
Fritsche et al. (2016)
Liu et al. (2010)
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(− 0.108 vs − 0.024) and that between refractive astigmatism 
and spherical equivalent was lower (− 0.104 vs. 0.773) than 
in the CREAM meta-analysis sample (Shah et al. 2018). 
Potential reasons for the lack of concordance were that the 
genetic correlations from the CREAM study were based on 
analyses of corneal and refractive astigmatism considered as 
dichotomous traits rather than continuous traits, the smaller 
sample size of the CREAM study, and the inclusion of par-
ticipants with a wider range of ages and ethnic backgrounds 
by CREAM. These methodological differences resulted in 
much less precise SNP-heritability and genetic correlation 
estimates in the CREAM study than were obtained here (the 
standard errors here were 5–10-fold lower than those in the 
CREAM study). Accordingly, the more precise results pre-
sented here (Table 4) are likely to represent a more accurate 
representation of the true genetic correlations.
Markers near the protein coding gene ZC3H11B (zinc 
finger CCCH-type containing 11B) on chromosome 1 (1q41) 
have previously demonstrated association with pathologi-
cal (high) myopia in Asian ancestry cohorts and with axial 
length in both European and Asian ancestry individuals 
(Cheng et al. 2013; Fan et al. 2012). Ocular expression of 
ZC3H11B has been identified in human retinal and scle-
ral tissues (Fan et al. 2012). LINC00340, also known as 
CASC15 (cancer susceptibility 15), is a long, non-coding 
RNA transcript located on chromosome 6 (6p22.3). In a 
previous meta-analysis of GWAS from European and Asian 
ancestry cohorts, this locus demonstrated genome-wide sig-
nificant association with spherical equivalent refractive error 
(Fan et al. 2016) and suggestive association (P < 1 × 10−5) 
with refractive astigmatism (Li et al. 2015). For both stud-
ies, associations at the locus appear to be largely driven by 
signals from European-ancestry cohorts, with little asso-
ciation demonstrated by their Asian ancestry counterparts. 
The protein coding gene HERC2 (HECT and RLD domain 
containing E3 ubiquitin protein ligase 2) and its neighbour-
ing gene OCA2 (Oculocutaneous albinism type 2) on chro-
mosome 15 (15q13.1) have both previously demonstrated 
association with eye, skin and hair pigmentation (Kayser 
et  al. 2008; Sturm and Larsson 2009; Liu et  al. 2010). 
TSPAN10 (Tetraspanin 10), also known as Oculospanin, is 
a protein-coding gene located within a gene-dense region 
on chromosome 17 (17q25.3). This gene regulates the trans-
membrane metalloprotease ADAM10 as part of the Notch 
signalling pathway (Charrin et al. 2014). Ocular expression 
of TSPAN10 has been identified in the iris, ciliary body and 
retinal pigment epithelium (Wistow et al. 2002) and this 
locus has previously demonstrated genome-wide significant 
association with eye colour, myopia and age-related macular 
degeneration (Pickrell et al. 2016; Fritsche et al. 2016; Liu 
et al. 2010). The identification of 3 genes (HERC2, OCA2 
and TSPAN10) associated with eye colour and astigmatism 
implies that certain eye colour(s) may confer susceptibility 
to astigmatism or that these eye colour-related genes have 
distinct, pleiotropic actions that lead to astigmatism. (While 
it is possible that astigmatism confers susceptibility to cer-
tain eye colours, or that susceptibility to both eye colour 
and astigmatism is mediated via an intermediate geneti-
cally determined trait, we consider these latter options less 
likely). It is notable that Pan et al. (2018) recently identified 
an association between iris colour (dark vs. light brown) and 
spherical equivalent refractive error in a sample of Chinese 
school children. Hence, the relationship between eye colour 
and refractive errors may be a promising avenue for further 
research.
Our primary GWAS analyses were conducted using 
mixed linear models as implemented in BOLT-LMM (Loh 
et al. 2015, 2018). Mixed linear models have the advan-
tage over standard linear regression that they can correct for 
residual population stratification and relatedness within the 
study sample, which can otherwise lead to reduced power 
or an excess of false positive association signals (Yang et al. 
2014). Due to the increased sample size the mixed linear 
model approach allows, the genome-wide significant associ-
ation signals obtained here were stronger than those obtained 
from standard linear regression. An important limitation of 
using mixed linear models for association studies is that they 
can produce unreliable results for dichotomous traits (Chen 
et al. 2016; Yang et al. 2014); hence, we only considered 
corneal and refractive astigmatism as continuous traits for 
the mixed model analyses. Nonetheless, the results were 
similar to those obtained using PLINK 2.0 with corneal and 
refractive astigmatism considered as continuous traits and 
as dichotomous traits defined using a threshold of 1.00 D for 
assigning case status (Online Resources 7–12).
It should be noted that the magnitudes of corneal and 
refractive astigmatism in this UK Biobank sample follow 
a similar change with age as observed in other European 
ancestry samples (Sanfilippo et al. 2015; Schuster et al. 
2017), with corneal astigmatism relatively stable with 
increasing age and refractive astigmatism gradually increas-
ing with age (Online Resource 1). Whilst these changes with 
age could influence the ability to detect genetic variants 
associated with these astigmatism traits, this was mitigated 
against by the inclusion of age as a quantitative covariate in 
all analyses. However, there may be some residual effects 
not accounted for.
As increasing magnitudes of astigmatism are correlated 
with increasing magnitudes of spherical refractive error 
(Guggenheim and Farbrother 2004; Kronfeld and Devney 
1930), spherical equivalent was included as a covariate to 
negate the effects of this correlation as a potential driver 
of association signals. Using spherical equivalent is more 
conservative an adjustment than using the spherical refrac-
tive component only, as this also adjusts for the contribution 
of refractive astigmatism to the overall refractive error of 
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the individual (Guggenheim and Farbrother 2004). Further 
sensitivity analyses, in which GWAS analyses were repeated 
without including spherical equivalent as a covariate, did not 
appreciably alter the findings.
In summary, we have conducted the largest genome-wide 
association studies for corneal and refractive astigmatism to 
date and identified four novel loci for corneal astigmatism, 
two of which are also novel loci for refractive astigmatism. 
It was notable that all of these novel loci have previously 
been associated with different ocular traits (Table 5), most 
prominently spherical equivalent refractive error. However, 
the astigmatism association signals were genome-wide 
significant even after adjusting for the effects of spheri-
cal equivalent, confirming that they represent independent 
associations, thus lending further support to the concept of 
shared genetic susceptibility for myopia and astigmatism.
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